Bioventus (BVS) EPS (Diluted) Growth (1y) (2022 - 2026)
Bioventus (BVS) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 13.96% |
| 10 | Bioventus | 975.28 Mn | 945.82 Mn | 105.67 Mn | 277.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 277.79% |
| Mar 28, 2026 | 212.00% |
| Apr 1, 2023 | -17,970.93% |
| Dec 31, 2022 | -69,220.06% |
| Oct 1, 2022 | -1,235.29% |
| Jul 2, 2022 | 98.23% |
| Apr 2, 2022 | -101.13% |